Skip to main content
Top
Published in: Supportive Care in Cancer 3/2021

01-03-2021 | Acupuncture | Review Article

Nonpharmacological therapies for the management of menopausal vasomotor symptoms in breast cancer survivors

Authors: Stephanie Tran, Martha Hickey, Christobel Saunders, Lesley Ramage, Paul A. Cohen

Published in: Supportive Care in Cancer | Issue 3/2021

Login to get access

Abstract

Purpose

Breast cancer affects millions of women worldwide, and for many, therapy results in treatment-induced menopause. Menopausal symptoms in breast cancer survivors are often more severe, frequent, and of greater duration compared with natural menopause. Hot flushes and night sweats pose a significant burden for many women, with limited therapeutic options as menopausal hormone therapy is contraindicated. Guidelines recommend non-hormonal pharmacological agents including clonidine, gabapentin, and some antidepressants. However, some women may be reluctant to use medications due to concerns about side effects. The aim of this narrative review was to appraise recent evidence for nonpharmacological treatments for vasomotor symptoms in breast cancer survivors including cognitive behavioural therapy, hypnosis, yoga, mindfulness, acupuncture, and lifestyle changes.

Methods

A literature search was conducted. Studies were included if they were randomised and involved breast cancer survivors and nonpharmacological treatments for menopausal vasomotor symptoms.

Results

Twelve studies met the criteria, and three studies of exercise in healthy menopausal women were included. Cognitive behavioural therapy reduces menopausal symptoms and perceived impact of hot flushes and night sweats in breast cancer survivors and is cost effective. The efficacy of hypnosis as a treatment for menopausal vasomotor symptoms in women with breast cancer is supported by two randomised controlled trials. Yoga and acupuncture may reduce vasomotor symptom frequency and/or burden. Studies of exercise as an intervention for vasomotor symptoms in healthy menopausal women have not shown benefit.

Conclusion

Evidence for nonpharmacological interventions supports cognitive behavioural therapy and hypnosis in the management of vasomotor symptoms in breast cancer survivors.
Literature
2.
go back to reference Maughan KL, Lutterbie MA, Ham PS (2010) Treatment of breast cancer. Am Fam Physician 81(11):1339–1346PubMed Maughan KL, Lutterbie MA, Ham PS (2010) Treatment of breast cancer. Am Fam Physician 81(11):1339–1346PubMed
3.
go back to reference Odle TG (2014) Adverse effects of breast cancer treatment. Radiol Technol 85(3):297–319 Odle TG (2014) Adverse effects of breast cancer treatment. Radiol Technol 85(3):297–319
12.
go back to reference Stubbs C, Mattingly L, Crawford SA, Wickersham EA, Brockhaus JL, McCarthy LH (2017) Do SSRIs and SNRIs reduce the frequency and/or severity of hot flashes in menopausal women. J Okla State Med Assoc 110(5):272–274PubMedPubMedCentral Stubbs C, Mattingly L, Crawford SA, Wickersham EA, Brockhaus JL, McCarthy LH (2017) Do SSRIs and SNRIs reduce the frequency and/or severity of hot flashes in menopausal women. J Okla State Med Assoc 110(5):272–274PubMedPubMedCentral
26.
go back to reference Duijts SFA, Mv B, Oldenburg HSA, Hunter MS, Kieffer JM, Stuiver MM, Gerritsma MA, Menke-Pluymers MBE, Plaisier PW, Rijna H, Cardozo AMFL, Timmers G, Svd M, Hvd V, Bijker N, Widt-Levert LM, Geenen MM, Heuff G, Dulken EJ, Boven E, Aaronson NK (2012) Efficacy of cognitive behavioral therapy and physical exercise in alleviating treatment-induced menopausal symptoms in patients with breast cancer: results of a randomized, controlled, multicenter trial. J Clin Oncol 30(33):4124–4133. https://doi.org/10.1200/jco.2012.41.8525CrossRefPubMed Duijts SFA, Mv B, Oldenburg HSA, Hunter MS, Kieffer JM, Stuiver MM, Gerritsma MA, Menke-Pluymers MBE, Plaisier PW, Rijna H, Cardozo AMFL, Timmers G, Svd M, Hvd V, Bijker N, Widt-Levert LM, Geenen MM, Heuff G, Dulken EJ, Boven E, Aaronson NK (2012) Efficacy of cognitive behavioral therapy and physical exercise in alleviating treatment-induced menopausal symptoms in patients with breast cancer: results of a randomized, controlled, multicenter trial. J Clin Oncol 30(33):4124–4133. https://​doi.​org/​10.​1200/​jco.​2012.​41.​8525CrossRefPubMed
29.
48.
go back to reference Lesi G, Razzini G, Musti MA, Stivanello E, Petrucci C, Benedetti B, Rondini E, Ligabue MB, Scaltriti L, Botti A, Artioli F, Mancuso P, Cardini F, Pandolfi P (2016) Acupuncture as an integrative approach for the treatment of hot flashes in women with breast cancer: a prospective multicenter randomized controlled trial (AcCliMaT). J Clin Oncol 34(15):1795–1802. https://doi.org/10.1200/jco.2015.63.2893CrossRefPubMed Lesi G, Razzini G, Musti MA, Stivanello E, Petrucci C, Benedetti B, Rondini E, Ligabue MB, Scaltriti L, Botti A, Artioli F, Mancuso P, Cardini F, Pandolfi P (2016) Acupuncture as an integrative approach for the treatment of hot flashes in women with breast cancer: a prospective multicenter randomized controlled trial (AcCliMaT). J Clin Oncol 34(15):1795–1802. https://​doi.​org/​10.​1200/​jco.​2015.​63.​2893CrossRefPubMed
53.
go back to reference Hunter M (2000) The women’s health questionnaire (WHQ): the development, standardization and application of a measure of mid-aged women’s emotional and physical health. Qual Life Res 9(1):733–738CrossRef Hunter M (2000) The women’s health questionnaire (WHQ): the development, standardization and application of a measure of mid-aged women’s emotional and physical health. Qual Life Res 9(1):733–738CrossRef
Metadata
Title
Nonpharmacological therapies for the management of menopausal vasomotor symptoms in breast cancer survivors
Authors
Stephanie Tran
Martha Hickey
Christobel Saunders
Lesley Ramage
Paul A. Cohen
Publication date
01-03-2021
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 3/2021
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-020-05754-w

Other articles of this Issue 3/2021

Supportive Care in Cancer 3/2021 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine